GROUP ONE TRADING, L.P. - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2019. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$650
-99.2%
5,609
-93.7%
0.00%
Q1 2021$83,000
+937.5%
88,435
+516.6%
0.00%
Q2 2020$8,000
+14.3%
14,343
-26.5%
0.00%
Q1 2020$7,000
-46.2%
19,516
+8.3%
0.00%
Q4 2019$13,000
-38.1%
18,016
-40.1%
0.00%
Q3 2019$21,000
-74.7%
30,063
-52.9%
0.00%
-100.0%
Q2 2019$83,000
-52.3%
63,823
-22.6%
0.00%
-50.0%
Q1 2019$174,000
+15.2%
82,490
+22.6%
0.00%
+100.0%
Q4 2018$151,000
-44.1%
67,305
-12.8%
0.00%
-50.0%
Q3 2018$270,000
+264.9%
77,156
+232.5%
0.00%
+100.0%
Q2 2018$74,000
-58.7%
23,203
-54.5%
0.00%
-50.0%
Q1 2018$179,000
-24.8%
51,014
-5.8%
0.00%0.0%
Q4 2017$238,000
-48.8%
54,127
-39.2%
0.00%
-50.0%
Q3 2017$465,000
-13.1%
88,972
-13.5%
0.00%
-33.3%
Q2 2017$535,000
+1810.7%
102,904
+1468.9%
0.01%
Q1 2017$28,000
-49.1%
6,559
-62.3%
0.00%
-100.0%
Q4 2016$55,000
+587.5%
17,392
+606.4%
0.00%
Q3 2016$8,000
+700.0%
2,462
+1039.8%
0.00%
Q4 2015$1,000
-87.5%
216
-89.8%
0.00%
Q1 2015$8,000
-71.4%
2,115
-54.2%
0.00%
Q4 2014$28,000
+16.7%
4,616
-11.7%
0.00%
Q3 2014$24,000
-46.7%
5,226
-44.6%
0.00%
-100.0%
Q2 2014$45,000
+2.3%
9,428
+36.1%
0.00%0.0%
Q1 2014$44,0006,9270.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q2 2019
NameSharesValueWeighting ↓
GROW Partners, LLC 325,000$2,077,0001.27%
DAFNA Capital Management LLC 125,000$799,0000.82%
BARD ASSOCIATES INC 170,925$1,094,0000.46%
MARXE AUSTIN W & GREENHOUSE DAVID M 525,000$3,355,0000.36%
SOPHROSYNE CAPITAL LLC 42,000$267,0000.23%
Granite Point Capital Management, L.P. 205,000$1,310,0000.22%
SABBY MANAGEMENT, LLC 407,024$2,601,0000.17%
SCOGGIN MANAGEMENT LP 150,000$959,0000.08%
Geduld E E 25,000$160,0000.08%
PRELUDE CAPITAL MANAGEMENT, LLC 45,000$288,0000.05%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders